Impact of maternal obesity on offspring adipose tissue: lessons for the clinic by Muhlhausler, B. & Vithayathil, M.
SUBMITTED VERSION 
 
Beverly S. Muhlhausler, and Mini A. Vithayathil 
Impact of maternal obesity on offspring adipose tissue: lessons for the clinic 
Expert Review of Endocrinology and Metabolism, 2014; 9(6):615-627 
 
 
Copyright © 2014 Informa Plc. All rights reserved. 
"This is a Submitted Manuscript of an article published by Taylor & Francis in Expert Review of 




























Author’s Original Manuscript (AOM) 
This is your original manuscript (often called a “preprint”), and you can share this as much as you like. As a Taylor & Francis 
author, you can post your Author’s Original Manuscript (AOM) on your departmental or personal website at any point 
after publication of your article (this includes posting to Facebook, Google groups, and LinkedIn, and linking from Twitter).  
To encourage citation of your work we recommend that you insert a link from your posted AOM to the published article on 
Taylor & Francis Online with the following text:  
"This is a Submitted Manuscript of an article published by Taylor & Francis in [JOURNAL TITLE] on [date of publication], 
available online: http://wwww.tandfonline.com/[Article DOI]."  
N.B. Using a real DOI will form a link to the Version of Record on Taylor & Francis Online.  
The AM is defined by the National Information Standards Organization as: 
 
Definition: The version of a journal article that has been accepted for publication in a 
journal. A second party (the “publisher”—see “Version of Record” below for 
definition) takes permanent responsibility for the article. Content and layout follow publisher’s submission requirements. 
 
1. Acceptance must follow some review process, even if limited to a single decision point about whether to publish or not. 
We recommend that there should be a link from the Accepted Manuscript to the journal’s website that describes its 
review process.  
 
2. If the Accepted Manuscript (AM) is processed in such a way that the content and layout is unchanged (e.g., by scanning 
or converting directly into a PDF), this does not alter its status as an AM. This will also apply to “normalized” files where, 
for example, an author’s Word file is automatically processed into some standardized form by the publisher. The content 
has not changed so this essentially constitutes a shift of format only, and our terms are format neutral. 
 
 3. This stage is also known as “Author’s Manuscript” by, for example, the NIH, but we believe that the key point is the 
acceptance of the manuscript by a second party. Elsevier refers to it as “Author’s Accepted Manuscript”. SHERPA/RoMEO 
refer to it as “Postprint”, but this term is counterintuitive since it implies that it refers to a version that comes after 
printing. 
 
13 December 2016 
1 
 
Impact of Maternal Obesity on Offspring Adipose Tissue: Lessons for the Clinic 1 
Beverly S Muhlhausler1,2, Mini A Vithayathil1 2 
1 FOODplus Research Centre, School of Agriculture Food and Wine, The University of 
Adelaide, Adelaide 5064, Australia 2 Sansom Institute for Health Research, School of 
Pharmacy and Medical Science, University of South Australia, Adelaide 5001, Australia 
 
Short title: Maternal Obesity and Offspring Fat 
 
*Please address all correspondence to: 
Dr Beverly Muhlhausler 
FOODplus Research Centre 
School of Agriculture Food and Wine 
The University of Adelaide 
Adelaide  5064 
Australia 
Phone    +61 8 8313 0848 
Fax:    +61 8 8313 7135 
Email:    beverly.muhlhausler@adelaide.edu.au 3 
 4 




Maternal obesity is a major risk factor for the subsequent development of obesity and type 2 7 
diabetes in the child. This relationship appears to be driven largely by the exposure of the 8 
fetus to an increased nutrient supply during critical periods of development, which results in 9 
persistent changes in the structure and function of key systems involved in the regulation of 10 
energy balance, appetite and fat deposition. One of the key targets is the fat cell, or adipocyte, 11 
in which prenatal overnutrition programs a heightened capacity for fat storage. The 12 
increasing prevalence of maternal obesity has led to an urgent need for strategies to break the 13 
resulting intergenerational cycle of obesity and metabolic disease. This review will discuss 14 
the relationship between maternal obesity and poor metabolic health of the offspring, with a 15 
particular focus on the involvement of adipose tissue, recent clinical studies examining 16 
potential strategies for intervention and priority areas for further research.  17 
 18 
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The world-wide increase in the prevalence of overweight and obesity has led to a 24 
corresponding increase in the number of women who are classified as overweight or obese 25 
when they enter pregnancy. Recent statistics from Australia and the US suggests that over 26 
50% of women have a body mass index (BMI) >25kg/m2 at the time of their first antenatal 27 
appointment, and there are predictions that this figure is likely to increase [1,2].  28 
Maternal obesity has both short- and long-term adverse consequences for the mother and her 29 
infant. Obese women have a significantly increased risk of a number of pregnancy 30 
complications, including gestational diabetes (GDM) and pre-eclampsia, and their infants 31 
have a higher incidence of neonatal morbidity and mortality [3,4]. Infants born to 32 
overweight/obese women are more likely to be born large for gestational age (LGA) or 33 
macrososmic (>4000g), require resuscitation at birth and to suffer from jaundice and neonatal 34 
hypoglycaemia [4,5].   35 
Most recently, attention has turned to the impact of maternal obesity on the longer term 36 
outcomes of the infants. Clinical studies from across the developed and developing world 37 
have provided compelling evidence that infants of overweight and obese mothers, in addition 38 
to being heavier at birth, have a significantly increased risk of obesity and associated 39 
metabolic disorders later in life [4,6]. This association between maternal obesity and the risk 40 
of obesity in the child has created an intergenerational cycle of obesity and metabolic disease, 41 
which threatens to continue to impact on the metabolic health of future generations.    42 
This review will focus on current understanding of the mechanisms which underlie the 43 
increased risk of obesity in infants of overweight/obese mothers, with a specific focus on the 44 
effects on adipose tissue development. It will summarise the current state of the field in this 45 
4 
 
area of research, and provide insights into the key challenges and opportunities over the 46 
coming 5 year period.  47 
 48 
Maternal Obesity: A New Obstetric Challenge 49 
The number of women entering pregnancy overweight or obese has risen dramatically in 50 
recent years, in line with the rising prevalence of obesity in the general population. Data from 51 
the US in the early to mid-2000s indicated that just over 30% of pregnant women were 52 
classified as overweight or obese [2], however more recent studies suggest that this figure is 53 
now likely to be closer to 50% [3]. This substantial rise in the number of overweight and 54 
obese pregnant women represents a major challenge to clinicians, since this sector of 55 
pregnant population is well-known to be at increased risk of a host of pregnancy 56 
complications [3]. Furthermore, this risk increases with increasing maternal BMI and the 57 
presence of other co-morbidities, including pre-pregnancy diabetes or hypertension. Women 58 
who enter pregnancy overweight or obese are at higher risk of developing gestational 59 
diabetes (GDM), pregnancy hypertension and pre-eclampsia. There is also a much greater 60 
risk of infants being large for gestational age or macrosomic (a birth weight >4000g), which 61 
creates difficulties during the delivery process, in particular shoulder dystosia, and the 62 
majority of these infants are delivered by caesarean section [4,7]. Pregnancies complicated by 63 
maternal obesity are also more likely to end in still birth or significant neonatal distress. The 64 
infants born to overweight and obese women are also at higher risk of neonatal complications 65 
than infants born to lean women, in particular post-natal hypoglycaemia, jaundice and 66 
admission to neonatal intensive care [3].  67 
 68 
While it is not unexpected that heavier mothers give birth to heavy infants, there is now 69 
compelling evidence that the adverse effects of maternal obesity extend beyond the 70 
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immediate postnatal period, and predispose the infant to an increased risk of obesity and its 71 
associated metabolic complications throughout child and adult life.  72 
Maternal Obesity and Nutrient Supply to the Developing Fetus 73 
The short and long term consequences of maternal overweight/obesity on the developing 74 
infant are thought to result from the exposure of the fetus to an excess nutritional supply 75 
during critical periods in its development [8-10]. This increased nutrient supply appears to be 76 
due to the combined effects of the tendency of overweight/obese women to consume diets 77 
which are poorer in quality than lean women [11] and the fact that these women also tend to 78 
be more insulin resistant than their lean counterparts [2] (Figure 1). While a reduction in 79 
insulin sensitivity in the mother is a normal adaptation to pregnancy, designed to maximise 80 
transfer of nutrients from mother to fetus  rather than them being utilised by maternal tissues, 81 
a large proportion of women in the overweight/obese population already have compromised 82 
insulin sensitivity (or indeed are already borderline diabetic) when they fall pregnant. In these 83 
cases, the normal adaptation to pregnancy can often progress to GDM, which is characterised 84 
by maternal hyperglycemia during both post-prandial and fasting periods.  85 
 86 
In addition to hyperglycemia in the mother, GDM is associated with elevated glucose 87 
concentrations in the developing fetus. This fetal hyperglycemia stimulates the fetal pancreas 88 
to secrete more insulin, resulting in fetal hyperinsulinemia which stimulates anabolic 89 
processes in the fetus and results in increased fetal growth and fat deposition [12]. This ‘fuel 90 
mediated teratogenesis’ was first described by Freinkel in the 1980s, is associated with the 91 
increased birth weight and risk of fetal macrosomia which are characteristic of infants of 92 
diabetic mothers. In addition to being heavier and fatter at birth, there is also compelling 93 
evidence from both clinical and epidemiological studies that infants born to diabetic mothers 94 
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are at higher risk of obesity and its associated metabolic disorders throughout childhood and 95 
adulthood [13,14] (Figure 1).  96 
The Underlying Mechanisms: The Role of Adipose Tissue 97 
There have been a large number of studies in both small and large experimental animals 98 
which have begun to shed light on the biological mechanisms which underlie the increased 99 
risk of obesity in infants born to overweight/obese mothers. In small animal studies, maternal 100 
obesity has most commonly been modelled by feeding rat/mouse dams on cafeteria or semi-101 
synthetic high-fat diets prior to pregnancy and during pregnancy and lactation [15,16]. We 102 
and others have consistently demonstrated that offspring born to dams fed on these types of 103 
diets have a significantly elevated body fat mass at weaning and remain heavier and fatter 104 
through the life course than offspring of dams fed on control diets [17-19]. Importantly, 105 
maternal high-fat and/or high-sugar diets have been associated with altered gene expression 106 
within both the adipose tissue and hypothalamic appetite-regulating networks of the 107 
offspring, which result in higher fat deposition and increased appetite drive (hyperphagia) in 108 
the offspring into adult life [18-20]. 109 
 110 
Studies in large mammals, such as sheep and pigs, have the advantage over studies in smaller 111 
animals that the ontogeny of fat development is much more similar to that in the human; i.e. 112 
fat cell development begins before birth and extends into early postnatal life. This differs 113 
from altical rodent species, in which fat development is virtually absent in utero and  114 
appreciable fat deposits only start to appear during the suckling period.  Some years ago, we 115 
developed a model of maternal overnutrition in the sheep in which pregnant ewes were fed 116 
~55% above their maintenance energy requirements (as specified by the Ministry of 117 
Agriculture, Fisheries and Food, UK [21]) in the later third of pregnancy, in order to mimic 118 
exposure of the fetus to a moderate increase in nutrient supply during the major period of 119 
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intrauterine fat development [22]. This maternal overnutrition was associated with significant 120 
increases in maternal glucose concentrations, and fetal glucose and insulin concentrations 121 
were also significantly increased in fetuses of over-fed ewes compared to fetuses of ewes fed 122 
at maintenance energy requirements [22].  123 
 124 
Using this model, we studied the effect of fetal hyperglycemia/hyperinsulinemia on fetal fat 125 
cells, and fat deposition in the lamb in the early postnatal period. We demonstrated that 126 
maternal overnutrition was associated with a significant increase in the expression of the key 127 
adipogeneic/lipogenic transcription factor, Peroxisome Proliferator Activated Receptor 128 
gamma (PPARγ), in the fetal perirenal adipose depot (the main fat depot in fetal life), in 129 
conjunction with an increase in the mRNA expression of key lipogeneic genes, lipoprotein 130 
lipase (LPL) and glycerol-3-phospahte dehydrogenase (G3PDH) [23]. Importantly, this 131 
upregulation of lipogeneic genes was associated with an increased accumulation of fat in the 132 
early postnatal period, and lambs of over-fed ewes had a significantly higher mass of 133 
subcutaneous fat relative to body weight by the end of the first month of life [24,25]. These 134 
results suggested, therefore, that prenatal hyperglycemia led to a precoical upregulation of 135 
lipogenic genes in adipose tissue, which resulted in increased fat deposition after birth. The 136 
importance of the increased availability of nutrients in driving these effects is highlighted by 137 
the presence of a direct relationship between fetal glucose concentrations and the level of 138 
PPARγ mRNA expression in the perirenal adipose tissue in late gestation – consistent with 139 
clinical evidence that intrauterine glucose concentrations provide a sensitive marker of fetal 140 
adiposity [26]. In other studies, we and others have also reported that infusing glucose 141 
directly into the fetal sheep in late gestation is associated with a significant increase in the 142 
size of the lipid droplets in fetal fat depots, fetal fat mass and in leptin mRNA expression in 143 
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fetal fat depots [27,28], providing further evidence of the central role of glucose supply in 144 
driving fat deposition in utero.  145 
 146 
In addition to effects of maternal overnutrition on the adipose tissue and fat mass, there were 147 
also significant effects on the regulation of appetite and feeding behaviour. Thus, lambs of 148 
over-fed ewes had a significantly higher milk intake over the first month of postnatal life, and 149 
did not appropriately upregulate the expression of the appetite-inhibiting neuropeptide, 150 
Cocaine and Amphetamine Regulated Transcript (CART) in response to a positive energy 151 
balance [25]. This appeared to be a result of a downregulation of the expression of the leptin 152 
receptor in the central appetite regulating centre of these lambs as their fat mass increased, 153 
consistent with the development of central resistance to the actions of leptin’s appetite-154 
suppressing actions [25]. These findings, summarised in Figure 2,  led us to hypothesise that 155 
the primary event in the pathway linking an increased nutrient supply in utero to increased 156 
propensity to obesity in postnatal life was the programming of an increased capacity for 157 
lipogenesis in fetal fat depots [9].  158 
 159 
These sheep studies are supported by the finding from studies in pigs, largely conducted by 160 
Hausman and colleagues, which examined the effect of maternal diabetes and obesity on the 161 
structural and functional development of fetal adipose tissue in late gestation. In these 162 
studies, diabetes in the sow was associated with increased adipose tissue mass in fetuses at 163 
112 days of gestation, without a change in body weight [29]. Importantly, the activity of key 164 
lipogenic genes, in particular lipoprotein lipase (LPL), was significantly upregulated in the fat 165 
depots of fetuses of diabetic sows, and the number and size of the lipid droplets within the 166 
fetal fat depots were significantly increased [29,30]. These observations supported the 167 
concept that fetal adipose de novo fatty acid synthesis was stimulated in diabetic pregnancies, 168 
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and is likely to represent the primary mechanism by which increased lipid accumulates in the 169 
offspring. In a separate series of studies, Hausman and colleagues studied the development of 170 
fat depots in fetal pigs from sows who were genetically obese, compared to lean controls. As 171 
in the fetuses of diabetic sows, the adipocytes of fetuses of obese sows were large, more 172 
abundant and had higher LPL activity in late gestation, and these changes preceded the onset 173 
of obesity in this genetically obese breed [31,32]. 174 
 175 
Taken together, the results of large animal studies suggest that fetal overnutition, induced as a 176 
result of either maternal obesity and/or maternal hyperglycemia, is associated with a 177 
precocial upregulation of lipogeneic genes in fetal adipose depots which persists after birth 178 
and is associated with an increased capacity for lipid storage in postnatal life, and consequent 179 
propensity to obesity.   180 
 181 
Maternal Obesity before Conception: Another Important Window  182 
While the majority of studies to date have focussed on the consequences of maternal obesity 183 
and/or overnutrition during pregnancy, there is mounting evidence that poor metabolic health 184 
in the mother prior to and immediately after conception may also have negative effects on the 185 
long-term metabolic health of the offspring. Both clinical and experimental studies have 186 
shown that maternal obesity/overnutrition in the periconceptional period, independent of the 187 
nutritional environment later in development, can result in altered development of the adipose 188 
tissue and increased propensity to obesity in the offspring later in life. In humans, it is clearly 189 
very difficult to separate the effects of these two periods in the vast majority of pregnancies, 190 
however it has been reported that maternal obesity is associated with poorer developmental 191 
competence and poorer quality oocytes – which has negative effects on subsequent embryo 192 
development [33,34].  193 
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The negative impact of maternal obesity prior to conception on long-term offspring 194 
development has also been demonstrated in experimental animal models. McMillen and 195 
colleagues conducted an elegant study in the sheep in which embryos were transferred from a 196 
donor ewe who had been fed either on a control diet or on a high plane of nutrition (to induce 197 
maternal weight gain) for the 4 months before conception to a lean recipient ewe at 6 d post-198 
conception, such that embryos of the ‘over-fed’ ewes were only exposed to the obesogenic 199 
environment during the periconceptional period [35]. The lambs from the ‘obese’ and ‘lean’ 200 
donor ewes were subsequently studied at 4 months of age. The study showed that female 201 
offspring exposed to maternal obesity in the periconceptional period had a higher fat mass as 202 
a percentage of body weight at 4 months of age compared to control lambs[35]. The study 203 
also determined whether these effects could be reversed by restricting the energy intake of the 204 
‘obese’ dams to induce weight loss in the period immediately prior to conception. While 205 
maternal weight loss in the ‘obese’ donors prevented the subsequent increase in fat mass in 206 
the lambs [35], periconceptional weight loss also resulted in heightened stress 207 
responsiveness, suggesting that maternal energy restriction diets before or in the early part of 208 
pregnancy may not be desirable [36,37].  209 
 210 
 211 
Implications for the Clinic 212 
In humans, as in sheep and pigs, the major period of fat development begins in late gestation 213 
and extends into the first year of life. The rising incidence of maternal overweight and 214 
obesity, coupled with the increased consumption of energy-dense, nutrient poor ‘junk’ foods, 215 
by pregnant and lactating women has led to growing concerns about the long-term 216 
consequences of this obesogenic environment on future generations. As a result, more recent 217 
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studies, in both humans and experimental animal models, have become increasingly focussed 218 
on identifying potential strategies for intervention. This is particularly important in light of 219 
the evidence from animal studies suggesting that the structural and functional changes 220 
induced in adipose (and other) tissues as a result of prenatal exposure to an increased nutrient 221 
supply in utero are very difficult, if not impossible, to reverse through nutritional 222 
interventions applied later in development [15,38,39]. In humans, three key windows of 223 
opportunity have been identified in relation to introducing nutritional interventions to 224 
improve long-term health outcomes in the offspring, namely prior to pregnancy, during 225 
pregnancy and in early infancy.  226 
Interventions Prior to Pregnancy 227 
As discussed above, the evidence showing that exposure to maternal obesity/overnutrition 228 
during the periconceptional period alone can result in an increased propensity for fat 229 
accumulation in the offspring suggests that, ideally, women who are overweight/obese should 230 
consider undertaking diet/lifestyle interventions to normalise body weight and improve 231 
metabolic health prior to conceiving. In addition, the fact that significant weight loss 232 
immediately before conception or in the early stages of pregnancy has the potential to 233 
negatively impact on the stress axis of the offspring [36], implies that any weight reduction 234 
program should be undertaken some time before the woman plans to conceive. To date, there 235 
have been no clinical trials in this area, and there remains an urgent need for research to 236 
enable evidence-based guidelines for the nutritional management of overweight/obese 237 






Interventions During Pregnancy  242 
While weight reduction/improved nutrition prior to pregnancy may be ideal, this is not 243 
always possible or practical, and pregnancies are not always planned and many clinicians do 244 
not see women until they are well into their pregnancy. As a result, the majority of clinical 245 
studies which have focussed on diet/lifestyle interventions introduced during pregnancy 246 
and/or lactation. A summary of some of the potential nutritional interventions which have 247 
been suggested/tested to date is presented in Figure 4, and the proposed interventions 248 
discussed in more detail in the following paragraphs. 249 
 250 
Early studies in this area focussed on the potential for interventions aimed at improving 251 
maternal glucose control to improve pregnancy/neonatal outcomes. The findings from two 252 
large-scale clinical studies, the Australian Carbohydrate Intolerance Study in Pregnant 253 
Women (ACHOIS) and the Maternal-Fetal Medicine Unit (MFMU) Network study, provided 254 
encouraging data which suggested that aggressive treatment of mild gestational diabetes, 255 
compared to routine care, resulted in reduced risks of pre-eclampsia, perinatal morbidity and 256 
fetal overgrowth (large for gestational age deliveries and fetal macrosomia) [40,41]. While 257 
the long-term consequences of these interventions on the fat mass/metabolic health of the 258 
children is not known, these studies nevertheless suggest that improving maternal glucose 259 
control, and thereby reducing maternal and fetal glycaemia, has the potential to improve the 260 
long term metabolic health outcomes of the child.  261 
The absorption of digested carbohydrate from foods in the form of glucose is the major 262 
dietary factor affecting postprandial blood glucose concentrations and insulin secretion, and 263 
as a result the quality and quantity of carbohydrates in the diet are key determinants of 264 
postprandial glucose concentrations[42]. The glycemic index (GI) describes the effects of 265 
different carbohydrate foods on blood glucose levels; carbohydrates that break down quickly 266 
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during digestion and release glucose rapidly into the bloodstream have a high GI whereas 267 
carbohydrates that break down more slowly, releasing glucose more gradually into the 268 
bloodstream, have a low GI. Thus, consumption of a low GI diet is associated with lower 269 
fasting and postprandial glucose concentrations than consumption of high GI diets [42]. Low 270 
GI diets have received significant attention in adult nutrition in relation to their effects on 271 
body weight and insulin action, and switching overweight and/or type 2 diabetic individuals 272 
from typical western diets to low GI diets can improve insulin sensitivity and assist with 273 
maintenance of weight loss [43-46]. 274 
The role of low GI diets in improving glucose control have led to suggestions that reducing 275 
the GI of diets consumed by women during pregnancy may have the potential to improve the 276 
metabolic health outcomes of the child by reducing maternal and fetal glucose 277 
concentrations. There is some evidence that adopting a low GI diet during pregnancy may 278 
offer benefits for maternal/child health, with a systematic review of human studies reporting 279 
that four of the eight studies carried out to date showed a protective association between low 280 
GI diets and pregnancy-related outcomes, and none showed negative effects [47]. In both 281 
normal and diabetic women in these studies birth weight, birth weight z-score and ponderal 282 
index of offspring were lower in women consuming the low GI diet compared to those 283 
consuming a standard Western diet or low-fat diet, and there was a reduced risk of delivering 284 
a large for gestational age or macrosomic infant [47,48]. Again, however, there are limited 285 
data on the potential for this intervention to improve the metabolic health of the offspring in 286 
the longer term. An exception is a recent study by Danielsen and colleagues, which reported a 287 
direct relationship between the GI of the maternal diet at gestational week 30 and markers of 288 
the metabolic syndrome, including fasting insulin, insulin sensitivity (assessed by HOMA-IR) 289 
and leptin, in the children at 20 years of age [49]. While interesting, it is important to note 290 
that this was an observational study, rather than a controlled trial, so it is not possible to 291 
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exclude the possibility of bias/confounding. Further follow-up of existing randomised trials 292 
will help to determine whether low GI diets may offer true potential to improve the metabolic 293 
health outcomes in offspring of diabetic mothers. Nevertheless, the available evidence 294 
suggests that low GI diets can be followed safely during pregnancy, and are associated with 295 
favourable effects in the mother, including reduced pregnancy weight gain, improved glucose 296 
tolerance and lower fasting glucose/insulin concentrations [47].  297 
More recently, two large-scale randomised controlled trials have specifically focussed on 298 
nutritional/lifestyle interventions in overweight/obese pregnant women for improving 299 
pregnancy/neonatal outcomes. The LIMIT study, led by Dodd and colleagues at the 300 
University of Adelaide, included over 2200 overweight and obese women who were 301 
randomised to receive either standard antenatal care or a comprehensive diet and lifestyle 302 
interventions in the second half of pregnancy [50]. As the name suggests, one of the principal 303 
aims of this study was to limit gestational weight gain in this population of pregnant women, 304 
since previous studies had suggested that a high percentage of overweight/obese pregnant 305 
women exceed the recommended weight gains for pregnancy, and that this is associated with 306 
poor pregnancy/neonatal outcomes [51]. The first results of the LIMIT trial, published in the 307 
British Medical Journal in early 2014, suggested that the nutritional and lifestyle intervention 308 
was associated with significant improvements in the nutritional quality of the maternal diet, 309 
but no differences in gestational weight gain in comparison with standard care [50]. Despite 310 
this however, there was a significant reduction in the number of babies born >4000g in the 311 
intervention arm, suggesting that the diet and lifestyle intervention had the potential to reduce 312 
the incidence of fetal overgrowth [50]. Importantly, these results also imply that it may be 313 
possible to achieve beneficial outcomes in the absence of reductions in gestational weight 314 
gain. The UPBEAT trial, led by Poston in the UK and colleagues, is another large-scale RCT 315 
which aims to test the ability of a complex diet and lifestyle intervention during pregnancy to 316 
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reduce the incidence of GDM and LGA deliveries (defined as a birth weight >4000g) [52]. 317 
Again, this study is specifically targeted towards overweight and obese women, and 318 
researchers aim to recruit in excess of 1500 pregnancies in order to achieve appropriate 319 
statistical power to test their primary hypotheses [52]. The results of these large scale RCTs, 320 
and further follow-ups of the children in these trials in order to examine the longer term 321 
metabolic outcomes will be important to guide policy and practice decisions in relation to the 322 
management of overweight and obese pregnancies.  323 
In addition to whole diet approaches to improving the metabolic health outcomes of children, 324 
interventions with specific nutrients, or combinations of nutrients, have also received some 325 
attention, particularly in relation to the level of omega-6 and omega-3 polyunsaturated fatty 326 
acids (n-6 and n-3 PUFA) in the maternal diet during pregnancy and lactation. This interest 327 
has stemmed largely from data derived from in vitro and adult rodent studies suggesting that 328 
these two classes of fatty acids have contrasting roles in relation to fat cell differentiation and 329 
lipid storage. These studies indicate that the n-3 PUFA, in particular the marine-derived long 330 
chain n-3 PUFA (n-3 LCPUFA) docosahexaenoic acid (DHA) and eicosapentaenoic acid 331 
(EPA), inhibit the proliferation and differentiation of pre-adipocytes [53,54] and inhibit the 332 
expression of the key lipogenic genes in adult adipose tissue, resulting in a reduced 333 
accumulation of lipid [55-58]. In contrast, the n-6 PUFA, LA and AA, have pro-adipogenic 334 
actions and promote the hyperplastic and hypertrophic expansion of adipose depots [53,59].  335 
 336 
These data have led to the suggestion that increasing the ratio of n-3 to n-6 PUFA in the 337 
maternal diet during pregnancy and/or lactation may be a potential strategy for reducing fat 338 
mass in the offspring [60]. To date there is little evidence from either animal or human 339 
studies to support this hypothesis [61,62]. However, there have been no attempts to date to 340 
determine whether specific sub-groups, for example women who consume poor quality diets 341 
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or are obese/overweight, could potentially benefit. The field awaits the outcomes of larger, 342 
adequately powered clinical studies to resolve this question.  343 
 344 
Management of Infants of Obese Mothers 345 
In human infants, fat development is not complete at birth, but continues throughout the first 346 
year of postnatal life [54]. Consequently, infant nutrition also plays an important role in 347 
defining an individual’s future risk of obesity. Importantly, data from animal studies provides 348 
evidence of an interaction between the prenatal and early postnatal nutritional environment in 349 
defining an individual’s risk of obesity and insulin resistance in the longer term. Thus, fat 350 
deposition and metabolic/cardiovascular deficits in offspring of rat dams fed on high-351 
fat/cafeteria diets during pregnancy and lactation are exacerbated when these offspring are 352 
also fed on high-fat diets after weaning [18].   353 
 354 
As discussed above, infants born to obese mothers are likely to be more susceptible to weight 355 
gain and fat disposition after birth compared to infants from lean women. Thus, close 356 
monitoring of the growth and nutritional intakes of these infants in the early postnatal period 357 
has the potential to provide a means of limiting the negative impacts of the intrauterine 358 
obesogenic environment. Research in this area is still in its infancy, and there are currently no 359 
specific guidelines for the management of infants of obese mothers, and this remains a fertile 360 
area for research. There have been some suggestions that encouraging ‘catch down’ growth, 361 
that is limiting the rate of infant weight gain, of infants who are born heavy at birth may be 362 
beneficial for reducing the subsequent risk of obesity, but studies in this area are lacking. It is 363 
also important to note that weight gain in and of itself does not always provide an appropriate 364 
measure of growth quality (i.e. lean vs fat mass), and assessment of body composition, and 365 
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the distribution of fat between subcutaneous and visceral fat compartments, is necessary to 366 
gain an overall picture of the growth profile of these infants.  367 
 368 
Perhaps the most important issue in relation to infant nutrition is the impact of breastfeeding 369 
vs formula feeding on long-term health outcomes. A number of systematic reviews have 370 
supported the suggestion that breastfeeding, particularly an extended duration of breast 371 
feeding, reduces the risk of obesity by ~20% in comparison with formula feeding [63]. It is 372 
important to note, however, that the biological effects are difficult to separate from social 373 
factors and that many of these studies were conducted at a time when the range of infant 374 
formulas available was much more restricted, such that the true effect size is difficult to 375 
assess. In addition, no studies of breast vs formula feeding in relation to obesity risk have 376 
specifically focussed on infants of obese mothers. It is also evident that the composition of 377 
the breast milk, in particular the fat content, varies markedly between women and closely 378 
related to the fatty acid composition of the maternal diet [64,65]. There is strong evidence 379 
that the n-3 and n-6 PUFA content in human breast milk are directly related to the content of 380 
these fatty acids in the maternal diet [54,66]. In addition, studies in rodents, including recent 381 
work in our laboratory, indicate that higher maternal intakes of saturated and trans fatty acids 382 
is directly related to increased content of these in the milk supply [67] (Vithayathil, Gibson & 383 
Muhlhausler, unpublished observations).  This implies that the composition of the maternal 384 
diet during lactation, as well as during pregnancy, is likely to be important in determining the 385 
long term metabolic health outcomes of the child.  386 
If the mother is unable to or chooses not to breastfeed, then the selection of an appropriate 387 
formula becomes important. Recent studies have implicated the higher protein content of 388 
infant formulas in comparison to human breast milk in the higher infant growth rates and 389 
18 
 
heighted obesity risk in formula fed infants [68], and one randomised controlled trial has 390 
suggested that feeding infants a formula with a lower protein content reduced their BMI and 391 
obesity risk at 6 years of age [69]. There has also been a recent randomised trial specifically 392 
focussed on infants of obese mothers, which reported that providing these infants with a 393 
lower protein formula was associated with a lower rate of weight gain between 3 and 6 394 
months of age [70]. Long-term follow up of the infants in this study to evaluate their long-395 
term outcomes in relation to fat deposition and metabolic health will provide critical insights 396 
into the potential utility of low protein formulas in the management of infants born to 397 
overweight/obese mothers.  398 
Expert Commentary 399 
The rising incidence of maternal obesity has led to an urgent need to identify appropriate and 400 
effective interventions to control the resulting intergenerational cycle of obesity and poor 401 
metabolic health. From early studies of development programming, largely focused on the 402 
metabolic consequences of exposure to sub-optimal nutrition intake [71], the attention of the 403 
developmental programming field has turned to the long-term consequences of periantal 404 
exposure to maternal obesity. It is clear from these studies that infants born to obese women 405 
are at increased risk of obesity and its related comorbidities as both children and adults, and 406 
this has created an intergenerational cycle of poor metabolic health which is fuelling the 407 
propagation of the obesity epidemic.  408 
 409 
While the underlying mechanisms are still being explored, the data to date suggests that it is 410 
exposure of the fetus/infant to an increased nutrient supply (in particular glucose and 411 
potentially fat) during critical periods of development which plays a central role in the early 412 
programming of obesity and metabolic disease. The work from our group and others suggests 413 
that the developing fat cell is a particularly important target of this metabolic programming, 414 
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and that exposure to an increased nutrient supply in utero results in persistent alterations in 415 
the structure/function of adipose cells which increases their capacity to store lipid in postnatal 416 
life. While not the topic of this review, there is also evidence that other key organs/regulatory 417 
systems, including the liver, skeletal muscle and central systems regulating appetite, reward 418 
processing and glucose control, are also impacted by prenatal nutritional excess (Figure 3). 419 
As a consequence of these programmed alterations in the structure and function of these 420 
systems, individuals exposed to an obesogenic environment in utero have an increased 421 
propensity to accumulate fat deposits after birth, and are therefore at increased risk of obesity.  422 
 423 
From this increased understanding of the biological mechanisms underpinning the 424 
relationship between maternal and infant/child obesity has come the recognition that the 425 
manifestations of prenatal overnutrition are largely permanent, and unlikely to be reversed by 426 
interventions applied later in life. Thus, while it may be possible to prevent excess weight 427 
gain by closely monitoring diet and physical activity, the heightened susceptibility to weight 428 
gain and obesity remains. As a result, it is clear that interventions to improve the metabolic 429 
health of infants of obese mothers need to be applied as early as possible in order to be 430 
effective in improving long term outcomes.  431 
 432 
More recently, research has turned toward potential interventions before and during 433 
pregnancy, and after birth, which could potentially improve the long-term metabolic health of 434 
the increasing number of infants whose mothers enter pregnancy overweight and obese. As 435 
highlighted above, while improving metabolic health well before conception is likely to be 436 
ideal, this is not always practical, and encouraging weight loss immediately prior to 437 
conception or in the early stages of pregnancy also appears to carry short and long-term risks. 438 
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For this reason, the majority of intervention studies have focussed on diet and lifestyle 439 
interventions applied during pregnancy.  440 
 441 
There is evidence from animal studies that maternal exercise may offer some benefits for 442 
offspring of mothers consuming high-fat/high-sugar junk food diets during pregnancy, 443 
however human studies suggest that increasing the physical activity in pregnant women is 444 
extremely challenging [50]. There is emerging evidence from large randomised controlled 445 
trials that improving the quality of the maternal diet during pregnancy independent of the 446 
level of physical activity and maternal weight gain, may reduce the incidence of LGA 447 
deliveries [50]. Further well-powered and robustly designed clinical studies are needed to 448 
determine whether specific nutritional interventions, for example increasing the supply of n-3 449 
LCPUFA, limiting n-6 PUFA intake or reducing the GI of the diet in overweight/obese 450 
women has the potential to reduce the subsequent risk of obesity/poor metabolic health in 451 
their offspring. In addition, there is growing interest in identifying potential approaches for 452 
management of infants of obese mothers to improve their long-term metabolic health; 453 
research in this area is currently extremely limited research, and more studies are urgently 454 
needed.  455 
 456 
 457 
Five-Year View  458 
As animal studies have provided new insights into the mechanisms which underlie 459 
developmental programming of obesity by nutritional exposures during the perinatal period, 460 
it has become increasingly clear that intervening early, preferably well before birth, to 461 
improve the nutritional environmental experienced during development is critical for 462 
improving long term metabolic health outcomes.  463 
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While there has been a move, both in experimental animal models and in clinical studies, 464 
towards research focussed on potential strategies for optimising the metabolic outcomes of 465 
infants from pregnancies complicated by maternal obesity, more such studies are desperately 466 
needed. Over the coming 5 years, the results of current large-scale RCTs in this area and of 467 
follow-up of the infants from these studies will start to emerge and will begin to develop a 468 
basis for clear evidence-based guidelines regarding the nutritional management of 469 
overweight/obese pregnant women.  470 
 471 
In addition, the ability to more accurately measure body composition and body fat 472 
distribution in infants will provide more insights into how different nutritional practices 473 
influence growth quality (as well as quantity), and whether specific nutritional modifications, 474 
such as increasing n-3 LCPUFA or reducing protein supply, in infants of obese mothers may 475 
help to improve their long-term metabolic health. The ability to conduct genetic and 476 
epigenetic studies in minute amounts of starting material, offers the potential to explore the 477 
mechanistic pathways underlying the early origins of human obesity in more detail than ever 478 
before, and the coming 5 years promises to see an explosion in the number of studies in this 479 
area.  480 
 481 
However, while technological advances will provide further insights into the underlying 482 
biology, it will be critical to ensure that the design of clinical trials to test nutritional 483 
interventions in pregnancy remains focussed on the core elements of the CONSORT 484 
statement; a defined nutritional intervention, appropriate controls, a defined primary 485 
outcome, adequate statistical power to address the primary question and, in the case of follow 486 
up studies, low rates of attrition to preserve the integrity of the randomisation [72]. While 487 
22 
 
epidemiological and cohort studies are important for identifying potential links, it is only 488 
through RCTs that we can confirm cause and effect relationships and establish definitely 489 
whether specific interventions are (a) safe and (b) effective in improving the long-term 490 
metabolic health outcomes in infants of overweight/obese mothers. Consequently, such 491 
studies will be important in the effective translation of this research into clinical practice over 492 
the coming 5 year time-frame. 493 
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 499 
Key issues 500 
1. Maternal obesity is a major risk factor for obesity and associated metabolic disorders 501 
in the child 502 
2. The association between maternal obesity and obesity in the child is a result of an 503 
increased nutrient supply to the fetus during critical periods of development 504 
3. The fat cell is a key target of this developmental programming, and exposure to an 505 
increased nutrient supply before birth prematurely ‘switches on’ key genes in adipose 506 
tissue which are responsible for lipid storage and this results in an increased 507 
propensity for fat accumulation after birth 508 
4. The increase in fat storage places the individual at increased risk of obesity and 509 
associated co-morbidities. 510 
5. These effects are not easily reversible – therefore early intervention is essential. 511 
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6. In humans, the major period of fat cell development before birth to first year of life 512 
7. Exposure to an increased nutrient supply during this period is an important 513 
determinant of fat cell size and number and the capacity for individuals for storing fat 514 
throughout the life course 515 
8. Current research is focussed on potential nutritional interventions to improve 516 
outcomes in infants born to overweight/obese mothers, but few results have been 517 
published to date 518 
9. There is an urgent need to accelerate this research, and to also focus on mechanistic 519 
studies in humans 520 
10. The next 5 years is likely to see a move to the development of specific guidelines for 521 
the nutritional management of overweight/obese mothers and their infants.   522 
 523 
 524 
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Figure Legends 775 
 776 
Figure 1. Schematic representation of the association between maternal 777 
obesity/overnutrition, increased fetal growth and increased risk of obesity in later life.  778 
 779 
Figure 2. Schematic of the proposed role of adipose tissue in the development of obesity and 780 
metabolic dysfunction after prenatal exposure to an excess energy supply. (1) Prenatal 781 
overnutrition results in increased expression PPARγ mRNA in visceral adipocytes before 782 
birth (2) After birth, signals from visceral adipocytes promote growth of the subcutaneous fat 783 
depot, leading to an increase in subcutaneous fat mass (3) Increased mass and leptin secretion 784 
from subcutaneous fat is associated with increased plasma leptin concentrations and 785 
development of central leptin resistance which leads to increased weight gain, obesity and 786 
ultimately metabolic dysfunction (from [9]). 787 
 788 
Figure 3. Summary of potential mechanisms implicated with the association between 789 
exposure to maternal obesity before birth and increased risk of obesity in later life (adapted 790 
from  791 
 792 
Figure 4. Nutritional interventions which may have potential to improve metabolic health of 793 
infants of obese mothers. Improving the overall quality of the maternal diet, increasing 794 
physical activity or reducing dietary GI during pregnancy could act either indirectly, through 795 
reducing pregnancy weight gain, or directly to improve maternal glucose tolerance and 796 
reduce fetal nutrient supply. Similarly, increased n-3 LPCUFA or decreasing n-6 PUFA 797 
intake may increase fetal n-3 LCPUFA supply and thereby reduce fetal fat deposition.  798 
